PMC:7402624 / 30145-30376
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T257 | 67-69 | Body_part | denotes | PB | http://purl.org/sig/ont/fma/fma84371 |
T258 | 138-140 | Body_part | denotes | PB | http://purl.org/sig/ont/fma/fma84371 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1100 | 218-229 | Gene | denotes | S5, B and C | Gene:6193 |
1107 | 18-26 | Species | denotes | patients | Tax:9606 |
1108 | 117-125 | Species | denotes | patients | Tax:9606 |
1122 | 48-52 | Chemical | denotes | cTfh | |
1123 | 67-69 | Chemical | denotes | PB | |
1124 | 138-140 | Chemical | denotes | PB | |
1125 | 195-199 | Chemical | denotes | cTfh |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T234 | 67-69 | Disease | denotes | PB | http://purl.obolibrary.org/obo/MONDO_0019035 |
T235 | 138-140 | Disease | denotes | PB | http://purl.obolibrary.org/obo/MONDO_0019035 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T515 | 38-47 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
T516 | 185-194 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
T517 | 218-220 | http://purl.obolibrary.org/obo/CLO_0008933 | denotes | S5 |
T518 | 222-223 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T207 | 67-69 | Chemical | denotes | PB | http://purl.obolibrary.org/obo/CHEBI_53319|http://purl.obolibrary.org/obo/CHEBI_60686 |
T209 | 138-140 | Chemical | denotes | PB | http://purl.obolibrary.org/obo/CHEBI_53319|http://purl.obolibrary.org/obo/CHEBI_60686 |
T211 | 218-220 | Chemical | denotes | S5 | http://purl.obolibrary.org/obo/CHEBI_29386 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T176 | 0-231 | Sentence | denotes | Furthermore, some patients had robust activated cTfh responses but PB frequencies similar to controls, whereas other patients with robust PB responses had relatively low frequencies of activated cTfh (Fig. 4F and fig. S5, B and C). |